Notify Therapeutics
PrivateLast Round
Seed
Sep 25, 2023
Total Funding Raised
$6.84M
Company Overview
Notify Therapeutics operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Seed round in September 2023.
Notify Therapeutics is a biotechnology company developing a first-in-class, non-hormonal fertility treatment for women with diminished ovarian reserve.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Notify Therapeutics Comparables
Compare Notify Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| U-Ploid Biotechnologies | 75% | |
| Granata Bio | 74% | |
| Celmatix | 64% |
For institutional investors. Book with your work email.
Notify Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 25, 2023 | ||||
| Seed | Feb 7, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Notify Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeckfonden BioCapital | Seed |
| +ND Capital | Seed |
| ND Capital | Seed |
| BioInnovation Institute | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 1081% MoM, reaching 2.6K.
- Sep 25, 2023
$5.3M raised, led by Lundbeckfonden BioCapital and ND Capital.
For institutional investors. Book with your work email.
Notify Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Notify Therapeutics's valuation, stock price, and market status.
Is Notify Therapeutics a public or private company?
Notify Therapeutics is a private company.
What is the current stock price of Notify Therapeutics?
Notify Therapeutics is a private company, so its shares have no public market price. Caplight tracks Notify Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Notify Therapeutics worth (valuation)?
Valuation information for Notify Therapeutics is not publicly available.
Can I buy Notify Therapeutics stock?
Notify Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Notify Therapeutics's last funding round?
Notify Therapeutics's most recent funding round was Seed on September 25, 2023.
Who are the main investors in Notify Therapeutics?
Key investors in Notify Therapeutics include Lundbeckfonden BioCapital, ND Capital, BioInnovation Institute.
Will Notify Therapeutics IPO soon?
No public IPO plans have been announced for Notify Therapeutics.
How can I track Notify Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Notify Therapeutics's shares on secondary markets.